Search clinical trials for: Clopidogrel

Total 816 results

University Hospital, Toulouse

Completed

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement (TIRATROP)

Atherosclerosis

France
Chinese PLA General Hospital

Unknown

Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS (GI-CT)

CLOPIDOGREL, POOR METABOLISM of (Disorder)

China
Korea University Anam Hospital

Completed

Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients (MECCA)

Angina, Stable
Ospedale San Donato

Completed

Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction (Load & Go)

Acute Myocardial Infarction

Italy
University of Pecs

Terminated

Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity (DOSER)

Stable Angina Pectoris | Ad Hoc Percutaneous Coronary Intervention

Hungary
Hospital Central San Luis Potosi, Mexico

Unknown

Patent Versus Generic Clopidogrel in Acute Coronary Syndrome

Acute Coronary Syndrome
University of North Carolina, Chapel Hill

Completed

Clopidogrel Pharmacogenomics Project

Disease Susceptibility

United States
Lady Reading Hospital, Pakistan
Pakistan Chest Society, Pakistan

Recruiting

Clopidogrel for the Prevention of Exacerbations in Severe COPD (CLOPEX)

COPD | COPD Exacerbation Acute

Pakistan
Deutsches Herzzentrum Muenchen

Terminated

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation (ISAR-CAUTION)

Coronary Artery Disease

Germany
Centre Hospitalier Universitaire de Saint Etienne

Completed

Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine (PLATINE)

Healthy

France
Vistamedi Ltd.
Tbilisi State Medical University

Active, not recruiting

The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models

Coronary Artery Disease | Death | Bleeding | Coronary Thrombosis | Hospitalisations | Clopidogrel Resistance | Adverse Cardiac Events | Death From Cardiovascular Disease

Georgia
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
University of Pecs
Hungarian Academy of Sciences; KRKA

Completed

Comparison of Generic and Original Formulation of Clopidogrel (DOSER-GENERIC)

Coronary Heart Disease | Percutaneous Coronary Intervention
Ajou University School of Medicine
Dong-A Pharmaceutical

Completed

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

Acute Coronary Syndrome

Korea, Republic of
The Third Xiangya Hospital of Central South University

Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Coronary Heart Disease

China
University of Pecs

Completed

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity (TREAT-HPR)

Acute Coronary Syndrome

Hungary
Sir Run Run Shaw Hospital

Unknown

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation (EASTS)

Coronary Artery Disease
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
Korea University Anam Hospital

Completed

Genotyping Influences Outcome of Coronary Artery Stenting (GENIUS)

Myocardial Ischemia | CLOPIDOGREL, POOR METABOLISM of (Disorder)
Khon Kaen University

Completed

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

Pharmacodynamics

Thailand
Creighton University

Completed

The Impact of Grapefruit Juice on the Response to Clopidogrel

Healthy

United States
Federico II University

Unknown

Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD (LONGDAPTPAD)

Peripheral Artery Disease

Italy
Ruhr University of Bochum

Completed

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan) (BOCLAplan)

Coronary Artery Disease

Germany
Shenyang Northern Hospital
Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD

Completed

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

Ischemic Heart Disease | Gastrointestinal Injury

China
Sheba Medical Center

Completed

Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS

Clopidogrel Non-Responsiveness

Israel
University Hospital Tuebingen

Completed

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Peripheral Vascular Diseases

Germany
Sanofi
Bristol-Myers Squibb

Completed

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

Metabolic Syndrome x

United States
Charles University, Czech Republic

Completed

Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?

Ischemic Heart Disease

Czech Republic
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (SWAP)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Clopidogrel and Response Variability Investigation Study 2 (CLOVIS2)

Coronary Artery Disease

France
Sanofi

Completed

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

Cerebral Infarction

Japan
Seoul National University Hospital
CKD Pharmaceutical Limited

Completed

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Coronary Heart Disease
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Migraine Prophylaxis With Clopidogrel Trial

Migraine

China
Novo Nordisk A/S

Completed

A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers

Healthy | Haemostasis

United States
Les Laboratoires des Médicaments Stériles
University Hospital Fattouma Bourguiba

Completed

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27 (PLATO-dose)

Cardiovascular Disease | Overweight

Tunisia
Portola Pharmaceuticals

Completed

A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI (INNOVATE-PCI)

Percutaneous Coronary Intervention

United States, Austria, Canada, Germany, Poland
Accumetrics, Inc.

Completed

GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety (GRAVITAS)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States, Canada
University Hospital, Bordeaux
Ministry for Health and Solidarity, France

Recruiting

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk (PSSIT)

Systemic Sclerosis | Scleroderma

France
Hospital Universitario Dr. Jose E. Gonzalez

Terminated

Comparative Bioavailability Study of Two Oral Formulations of Clopidogrel

Comparative Bioavailability of Clopidogrel Tablets

Mexico
University Hospital, Angers

Unknown

Platelets Induced Vasodilation, in Vitro and in Vivo Study

Peripheral Arterial Disease

France
Sanofi
Bristol-Myers Squibb

Completed

Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)

Blood Platelet Disorders | Congenital Heart Defects

United States, France, Canada, Germany, Italy, Belgium
Joint Stock Company "Farmak"

Completed

Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.

Pharmacokinetics

Ukraine
Wroclaw Medical University

Recruiting

Effects of P2Y12 Receptor Inhibitors on Central and Peripheral Chemoreceptors' Sensitivity

Dyspnea

Poland
First Affiliated Hospital of Harbin Medical University
RenJi Hospital; Shengjing Hospital; Beijing Anzhen Hospital; Shaanxi Provincial... and other collaborators

Completed

Efficacy and Safety of Low-dose Ticagrelor

Coronary Artery Disease

China
Jiangsu vcare pharmaceutical technology co., LTD

Completed

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

Healthy Subjects | PK/PD

China
Charles University, Czech Republic

Temporarily not available

Clopidogrel Resistance and the Possibility of Its Affection

Coronary Artery Disease

Czechia
Sheba Medical Center

Unknown

Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI

Platlet Aggregation | Major Bleeding Outcomes

Israel
University Heart Center Freiburg - Bad Krozingen

Completed

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Coronary Artery Disease | Drug Resistance

Germany
University of Florida
Scott R. MacKenzie Foundation

Completed

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

Coronary Artery Disease (CAD) | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD)

United States

Search clinical trials for: Clopidogrel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations